These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 2410365)
1. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1. Pluschke G; Achtman M Infect Immun; 1985 Aug; 49(2):365-70. PubMed ID: 2410365 [TBL] [Abstract][Full Text] [Related]
2. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Pluschke G; Mayden J; Achtman M; Levine RP Infect Immun; 1983 Dec; 42(3):907-13. PubMed ID: 6196296 [TBL] [Abstract][Full Text] [Related]
3. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection. Schiff DE; Wass CA; Cryz SJ; Cross AS; Kim KS Infect Immun; 1993 Mar; 61(3):975-80. PubMed ID: 7679376 [TBL] [Abstract][Full Text] [Related]
4. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo. Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199 [TBL] [Abstract][Full Text] [Related]
5. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns. Pluschke G; Achtman M Infect Immun; 1984 Feb; 43(2):684-92. PubMed ID: 6198283 [TBL] [Abstract][Full Text] [Related]
6. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model. Vuopio-Varkila J; Karvonen M; Saxén H J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461 [TBL] [Abstract][Full Text] [Related]
7. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection. Colino J; Outschoorn I Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459 [TBL] [Abstract][Full Text] [Related]
8. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains. Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500 [TBL] [Abstract][Full Text] [Related]
9. Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types. Pluschke G; Mercer A; Kusećek B; Pohl A; Achtman M Infect Immun; 1983 Feb; 39(2):599-608. PubMed ID: 6187683 [TBL] [Abstract][Full Text] [Related]
10. Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice. Smith HW; Huggins MB J Hyg (Lond); 1985 Oct; 95(2):363-74. PubMed ID: 3905956 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge. Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883 [TBL] [Abstract][Full Text] [Related]
12. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. McCabe WR; Kaijser B; Olling S; Uwaydah M; Hanson LA J Infect Dis; 1978 Jul; 138(1):33-41. PubMed ID: 355575 [TBL] [Abstract][Full Text] [Related]
13. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity. Smith HW; Huggins MB J Gen Microbiol; 1980 Dec; 121(2):387-400. PubMed ID: 7021764 [TBL] [Abstract][Full Text] [Related]
14. Roles of spleen and liver in the clearance of Escherichia coli K1 bacteraemia in infant rats. Pelkonen S; Pluschke G Microb Pathog; 1989 Feb; 6(2):93-102. PubMed ID: 2654535 [TBL] [Abstract][Full Text] [Related]
15. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli. Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122 [TBL] [Abstract][Full Text] [Related]
16. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Bortolussi R; Fischer GW Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443 [TBL] [Abstract][Full Text] [Related]
17. Use of hybridoma immunoglobulin switch variants in the analysis of the protective properties of anti-lipopolysaccharide antibodies in Escherichia coli K1 infection. Pelkonen S; Pluschke G Immunology; 1989 Oct; 68(2):260-4. PubMed ID: 2680911 [TBL] [Abstract][Full Text] [Related]
18. Protection against Escherichia coli K1 infection in newborn rats by antibody to K1 capsular polysaccharide antigen. Bortolussi R; Ferrier P Infect Immun; 1980 Apr; 28(1):111-7. PubMed ID: 6769816 [TBL] [Abstract][Full Text] [Related]
19. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953 [TBL] [Abstract][Full Text] [Related]
20. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation. Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]